MedElevator Войти в исследования
← Поиск публикаций

DOI 10.64898/2026.07.11.26357570

Медицинская библиотека · medRxiv : the preprint server for health sciences · 2026

Psilocybin-Assisted Early Palliative Care for Demoralization and Chronic Pain: An Open-Label Pilot Study.

Zarrabi Ali J, Mletzko Tanja, Grant George, Peacock Caroline, Palitsky Roman, McPherson Tarrant, Shub Isabelle, Eisenacher Sarah, Maples-Keller Jessica L, Kaplan Deanna, Rothbaum Barbara O, Rab Fayzan, Dalal Nupur, Curseen Kimberly A, Raison Charles, Dunlop Boadie W

СтатьяПрепринтПеревод в очереди

Аннотация

BACKGROUND

Demoralization, a syndrome of helplessness, hopelessness, and loss of meaning and chronic pain are common sources of distress in early palliative care. Psilocybin-assisted therapy (PAT) is an emerging intervention with preliminary data suggesting improvements in pain and demoralization. To date, PAT has not been studied among people living with both demoralization and chronic pain nor has it been studied as part of routine multidisciplinary outpatient palliative care.

OBJECTIVES

We conducted an open-label pilot study assessing the safety, feasibility, and acceptability of PAT delivered with multidisciplinary palliative care support in cancer patients across the illness trajectory living with demoralization and chronic pain.

METHODS

Participants received a single 25 mg oral dose of psilocybin with preparation, monitoring, and integration provided by a mental health clinician and spiritual health clinician, alongside multidisciplinary palliative care support. Outcomes included safety, feasibility, acceptability, and exploratory self-report measures assessing for demoralization and pain intensity pre- and post-dosing.

RESULTS

Eleven participants were enrolled, ten of whom received psilocybin. The intervention was safe and feasible, with no serious adverse events and complete study visit retention among dosed participants. All 10 dosed participants reported the intervention as highly acceptable. Among dosed participants, 70% rated the experience among the five most meaningful and educational of their lives, and 60% among their five most spiritually significant experiences. By study endpoint, 90% no longer met criteria for clinically-significant demoralization syndrome and had pain scores below the trial enrollment threshold.

CONCLUSIONS

PAT delivered with multidisciplinary palliative care support was safe, feasible, and acceptable in demoralized cancer patients with chronic pain.

KEY MESSAGE: Psilocybin-assisted therapy delivered within multidisciplinary outpatient palliative care was safe, feasible, and acceptable among demoralized cancer patients with chronic pain.

Для цитирования: Zarrabi Ali J, Mletzko Tanja, Grant George, Peacock Caroline, Palitsky Roman, McPherson Tarrant, Shub Isabelle, Eisenacher Sarah, Maples-Keller Jessica L, Kaplan Deanna, Rothbaum Barbara O, Rab Fayzan, Dalal Nupur, Curseen Kimberly A, Raison Charles, Dunlop Boadie W. Psilocybin-Assisted Early Palliative Care for Demoralization and Chronic Pain: An Open-Label Pilot Study.. medRxiv : the preprint server for health sciences. 2026. DOI: 10.64898/2026.07.11.26357570.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.